Novo Nordisk A/S
CPSE:NOVO B
kr 247,90
kr-0,75 (-0,30%)
247,90 kr
kr-0,75 (-0,30%)
End-of-day quote: 03/06/2026

Quick Analysis

The quick analysis data is updated as follows:

  • G (Growth Rate): Every 3 months when the company releases quarterly figures.
  • R (Risk Analysis): Every 12 months when the company publishes its annual financial statements.
  • O (Outlook): At the daily closing price.
  • W (Margin of safety): At the daily closing price.
  • T (Analyst Price Target): At the daily closing price.
  • H (Trend): At the weekly closing price.

A word about the trend:

The trend is not updated daily, as the GROWTH strategy is based on weekly prices. If necessary, you can check the valuation chart to see if the price has broken the daily trend.

G
20,54%
5-year Growth Rate
R
5/6
5-year Risk Analysis
O
-8,48%
Outlook 12/26
W
65,56%
Margin of safety
T
24,65%
Analyst Price Target
H
DOWN
50-week EMA Trend

Company Info

EPS Growth 5Y
20,65%
Revenue growth 5Y
20,44%
Price growth 5Y
12,76%
Market Cap
kr1.104,89 B
Long-Term Debt
kr110,37 B
Quarterly earnings
05/07/2026 (E)
Dividend
kr11,68
Dividend Yield
4,71%
Industry
Country
ISIN Number

Novo Nordisk A/S Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Analyst Price Target

kr309,00
24.65%
24.65
Last Update: 03/07/2026
Analysts: 21

Highest Price Target kr540,00

Average Price Target kr309,00

Lowest Price Target kr250,00

Top growth stocks in the health care sector

Stock Rate of Return 5Y Price 5Y Div. 5Y G R O W T H
Novo Nordisk A/S
CPSE:NOVO B
37,73% 12,76% 24,98% 20,54% 5/6 -8,48% 65,56% 24,27% DOWN
×